118 results
Page 5 of 6
6-K
EX-99.1
1mjnf4ubfi8li
6 Aug 20
European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells Activation
8:49am
6-K
EX-99.1
lxhi0erhmoor2jk3bjqt
21 May 20
Report of Foreign Private Issuer
4:27pm
6-K
EX-99.1
cg9k6dyjv3f
11 May 20
Report of Foreign Private Issuer
6:01am
6-K
EX-99.1
nwxg1
3 Apr 20
Cellect Biotechnology Reports Fourth Quarter and Full Year 2019 Results
8:05am
424B5
nxhq2 wv44p59hvsx5
10 Jan 20
Prospectus supplement for primary offering
8:42am
6-K
EX-10.1
9dsyl
10 Jan 20
Report of Foreign Private Issuer
8:37am
6-K
EX-99.1
qlh3p8mhix889mmm1k0e
7 Jan 20
Cellect Biotechnology Strengthens IP Portfolio; Receives “Intention to Grant” Patents from European and Israeli Patent Offices
7:00am
6-K
EX-99.1
77rv6o2qqzor
23 Dec 19
Cellect Biotechnology Receives Approval for U.S. Clinical Trial
7:00am
6-K
mqrl54ry89wf7 bv7km
6 Nov 19
Report of Foreign Private Issuer
8:38am
6-K
EX-99.3
y842h13tt508th96fs
13 Aug 19
Interim Consolidated Financial Statements
8:20am
6-K
EX-99.2
smw3rqsvoe8
13 Aug 19
Interim Consolidated Financial Statements
8:20am
6-K
i4cozqu08tcqvojgpi
12 Aug 19
Report of Foreign Private Issuer
7:20am
6-K
EX-99.1
d4twa86
12 Aug 19
Report of Foreign Private Issuer
7:20am
6-K
EX-99.1
12ppcl qu
8 Jul 19
Finalize Accelerated Clinical Trial Agreement
7:12am
6-K
EX-99.1
w9s7eig
30 Apr 19
Report of Foreign Private Issuer
4:33pm
6-K
EX-99.1
jyhaulscngb24zvxrk
27 Mar 19
Cellect Announces Positive Phase I/II Mid-Study Results of its ApoGraft™ Technology
8:14am
POS AM
mdjcy6k8cgk2b
26 Mar 19
Prospectus update (post-effective amendment)
5:25pm
6-K
EX-99.1
191ts54lt t6
18 Mar 19
Cellect Biotechnology Reports Fourth Quarter and Full Year 2018 Results and Recent Corporate Progress
4:27pm